{
    "id": 26915,
    "fullName": "RAD51D S207L",
    "impact": "missense",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "RAD51D S207L lies within the Walker B motif of the Rad51d protein (PMID: 28646019). S207L results in impaired homologous recombination, as demonstrated by disruption of the interaction between Rad51d and Xrcc2 and decreased Rad50 accumulation in response to DNA damage in cultured cells (PMID: 28646019).",
            "references": [
                {
                    "id": 9769,
                    "pubMedId": 28646019,
                    "title": "Functionally Null RAD51D Missense Mutation Associates Strongly with Ovarian Carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28646019"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5892,
        "geneSymbol": "RAD51D",
        "terms": [
            "RAD51D",
            "BROVCA4",
            "R51H3",
            "RAD51L3",
            "TRAD"
        ]
    },
    "variant": "S207L",
    "createDate": "08/23/2017",
    "updateDate": "10/01/2019",
    "referenceTranscriptCoordinates": {
        "id": 133700,
        "transcript": "NM_002878",
        "gDna": "chr17:g.35103501G>A",
        "cDna": "c.620C>T",
        "protein": "p.S207L",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11795,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cells expressing RAD51D S207L demonstrated decreased survival when treated with Talazoparib (BMN-673) in culture (PMID: 28646019).",
            "molecularProfile": {
                "id": 28250,
                "profileName": "RAD51D S207L"
            },
            "therapy": {
                "id": 682,
                "therapyName": "Talazoparib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9769,
                    "pubMedId": 28646019,
                    "title": "Functionally Null RAD51D Missense Mutation Associates Strongly with Ovarian Carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28646019"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11794,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cells expressing RAD51D S207L demonstrated decreased survival when treated with Lynparza (olaparib) in culture (PMID: 28646019).",
            "molecularProfile": {
                "id": 28250,
                "profileName": "RAD51D S207L"
            },
            "therapy": {
                "id": 837,
                "therapyName": "Olaparib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9769,
                    "pubMedId": 28646019,
                    "title": "Functionally Null RAD51D Missense Mutation Associates Strongly with Ovarian Carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28646019"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 28250,
            "profileName": "RAD51D S207L",
            "profileTreatmentApproaches": [
                {
                    "id": 14711,
                    "name": "PARP Inhibitor (Pan)",
                    "profileName": "RAD51D S207L"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 133700,
            "transcript": "NM_002878",
            "gDna": "chr17:g.35103501G>A",
            "cDna": "c.620C>T",
            "protein": "p.S207L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}